We are live on
!
Find out more
Rafferty Asset Management Portfolio holdings
AUM
$24.6B
1-Year Est. Return
47.06%
This Fund
S&P 500
This Quarter
Est. Return
+14.54%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$30.8B
AUM Growth
+$518M
(+1.7%)
Cap. Flow
-$2.73B
Cap. Flow
% of AUM
-8.84%
Top 10 Holdings %
Top 10 Hldgs %
39.95%
Holding
1,143
New
66
Increased
528
Reduced
508
Closed
39
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Astera Labs
ALAB
|
+$176M |
| 2 |
Credo Technology Group
CRDO
|
+$154M |
| 3 |
MACOM Technology Solutions
MTSI
|
+$71.5M |
| 4 |
Rambus
RMBS
|
+$69.5M |
| 5 |
NVMI
Nova
NVMI
|
+$68.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$386M |
| 2 |
NVIDIA
NVDA
|
+$300M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$272M |
| 4 |
Broadcom
AVGO
|
+$248M |
| 5 |
Qualcomm
QCOM
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 45.44% |
| 2 | Financials | 9.98% |
| 3 | Consumer Discretionary | 8.65% |
| 4 | Healthcare | 3.7% |
| 5 | Industrials | 2.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SFIX
1026
Stitch Fix
SFIX
$536M
| $251K | ﹤0.01% |
57,747
+1,164
| +2% | +$5.75K |
|
1027
Corcept Therapeutics
CORT
$12.4B
| $251K | ﹤0.01% |
3,019
-317
| -10% | -$22.9K |
|
1028
American Airlines Group
AAL
$10.1B
| $250K | ﹤0.01% |
22,250
-5,680
| -20% | -$70K |
|
1029
Compass Therapeutics
CMPX
$344M
| $248K | ﹤0.01% |
+70,959
| New | +$224K |
|
|
ORKA
1030
Oruka Therapeutics
ORKA
$5.82B
| $246K | ﹤0.01% |
+12,787
| New | +$190K |
|
1031
Jones Lang LaSalle
JLL
$16.3B
| $244K | ﹤0.01% |
819
-9
| -1% | -$2.57K |
|
1032
Watsco Inc
WSO
$12.7B
| $244K | ﹤0.01% |
603
-6
| -1% | -$2.57K |
|
1033
Gentex
GNTX
$4.97B
| $243K | ﹤0.01% |
+8,596
| New | +$228K |
|
1034
Graco
GGG
$12.9B
| $243K | ﹤0.01% |
2,863
-55
| -2% | -$4.71K |
|
1035
Carlisle Companies
CSL
$14.3B
| $242K | ﹤0.01% |
737
-18
| -2% | -$6.86K |
|
1036
Shift4
FOUR
$4.2B
| $242K | ﹤0.01% |
3,126
+591
| +23% | +$54.9K |
|
1037
Caleres
CAL
$431M
| $242K | ﹤0.01% |
18,532
-1,512
| -8% | -$21.9K |
|
1038
Cullinan Oncology
CGEM
$1.01B
| $242K | ﹤0.01% |
40,729
+1,503
| +4% | +$11K |
|
1039
ITT
ITT
$17.5B
| $241K | ﹤0.01% |
1,348
-27
| -2% | -$4.53K |
|
1040
Arbutus Biopharma
ABUS
$857M
| $241K | ﹤0.01% |
53,008
-35,446
| -40% | -$130K |
|
1041
XPeng
XPEV
$12.4B
| $241K | ﹤0.01% |
+10,273
| New | +$206K |
|
1042
Nu Holdings
NU
$69.2B
| $238K | ﹤0.01% |
14,879
-1,323
| -8% | -$18.5K |
|
1043
Tarsus Pharmaceuticals
TARS
$2.58B
| $237K | ﹤0.01% |
3,980
-1,790
| -31% | -$88.1K |
|
1044
Riot Platforms
RIOT
$7.63B
| $236K | ﹤0.01% |
12,379
+1,395
| +13% | +$19.3K |
|
1045
Ligand Pharmaceuticals
LGND
$5.76B
| $231K | ﹤0.01% |
+1,303
| New | +$194K |
|
1046
Royal Gold
RGLD
$16.8B
| $228K | ﹤0.01% |
1,137
-12
| -1% | -$2.08K |
|
1047
Gaming and Leisure Properties
GLPI
$12.7B
| $228K | ﹤0.01% |
4,890
-1,318
| -21% | -$62.1K |
|
|
CFLT
1048
DELISTED
Confluent
CFLT
| $228K | ﹤0.01% |
11,490
-341
| -3% | -$7.13K |
|
1049
Fabrinet
FN
$15.6B
| $226K | ﹤0.01% |
+619
| New | +$204K |
|
1050
MasTec
MTZ
$21.1B
| $225K | ﹤0.01% |
+1,059
| New | +$194K |
|
Similar funds
CS
AF
SC
JG
Rafferty Asset Management's Q3 2025 Portfolio in Review
As of Q3 2025, Rafferty Asset Management held 1,143 positions worth $30.8B, up 1.7% from $30.3B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Rafferty Asset Management withdrew a net $2.73B in Q3 2025, closing 39 positions and reducing 508 holdings. Its most notable exit was Qorvo, an estimated $103M position sold in full.
By sector, the portfolio is most concentrated in Technology at 45% of assets, down from 49% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Rafferty Asset Management opened a new position in Astera Labs worth $210M.
- Rafferty Asset Management's largest Q3 2025 buy was Astera Labs: 1,070,475 shares worth $210M.
- Rafferty Asset Management added most to Invesco QQQ Trust in Q3 2025, an estimated $42.9M increase.
- Rafferty Asset Management's biggest Q3 2025 reduction was Advanced Micro Devices, cutting an estimated $386M.
- Rafferty Asset Management fully exited Qorvo in Q3 2025, selling an estimated $103M.
- Rafferty Asset Management's ten largest holdings make up 40% of its $30.8B portfolio in Q3 2025.
- Rafferty Asset Management opened 66 new positions and closed 39 in Q3 2025.
- Rafferty Asset Management's portfolio value rose 1.7% quarter-over-quarter to $30.8B.
Based on Rafferty Asset Management's 13F filing for Q3 2025, filed 12 Nov 2025.